Literature DB >> 21380930

Discrepancy in the kinetics of total and active anti-thymocyte globulin blood concentrations in recipients of allogeneic hematopoietic stem cell transplantation.

Akiko Yamane1,2, Takehiko Mori3, Jun Kato1,2, Yukako Ono1, Shinichiro Okamoto1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21380930     DOI： 10.1007/s12185-011-0778-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  13 in total

Review 1.  Mechanisms of action of antithymocyte globulin: old dogs with new tricks!

Authors:  Mohamad Mohty; Beatrice Gaugler
Journal:  Leuk Lymphoma       Date:  2008-09

2.  Total and active thymoglobulin levels: effects of dose and sensitization on serum concentrations.

Authors:  J F Regan; C Lyonnais; K Campbell; L V Smith; R Buelow
Journal:  Transpl Immunol       Date:  2001-10       Impact factor: 1.708

3.  Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation.

Authors:  Markus G Seidel; Gerhard Fritsch; Susanne Matthes-Martin; Anita Lawitschka; Thomas Lion; Ulrike Pötschger; Agathe Rosenmayr; Gottfried Fischer; Helmut Gadner; Christina Peters
Journal:  J Pediatr Hematol Oncol       Date:  2005-10       Impact factor: 1.289

4.  Protective conditioning for acute graft-versus-host disease.

Authors:  Robert Lowsky; Tsuyoshi Takahashi; Yin Ping Liu; Sussan Dejbakhsh-Jones; F Carl Grumet; Judith A Shizuru; Ginna G Laport; Keith E Stockerl-Goldstein; Laura J Johnston; Richard T Hoppe; Daniel A Bloch; Karl G Blume; Robert S Negrin; Samuel Strober
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

Review 5.  Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects.

Authors:  A Bacigalupo
Journal:  Bone Marrow Transplant       Date:  2005-02       Impact factor: 5.483

6.  Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities.

Authors:  Sung-Eun Lee; Hee-Je Kim; Woo-Sung Min; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Chang-Ki Min; Seok Lee; Seok-Goo Cho; Dong-Wook Kim; Jong-Wook Lee; Chong-Won Park; Chun-Choo Kim
Journal:  Int J Hematol       Date:  2010-08-10       Impact factor: 2.490

7.  Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen.

Authors:  Mohamad Mohty; Jacques-Olivier Bay; Catherine Faucher; Bachra Choufi; Karin Bilger; Olivier Tournilhac; Norbert Vey; Anne-Marie Stoppa; Diane Coso; Christian Chabannon; Patrice Viens; Dominique Maraninchi; Didier Blaise
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

8.  Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.

Authors:  Edmund K Waller; Amelia A Langston; Sagar Lonial; Judy Cherry; Jyoti Somani; Andrew J Allen; Hilary Rosenthal; Istvan Redei
Journal:  Biol Blood Marrow Transplant       Date:  2003-07       Impact factor: 5.742

9.  Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.

Authors:  Takehiko Mori; Yoshinobu Aisa; Reiko Watanabe; Rie Yamazaki; Jun Kato; Takayuki Shimizu; Naoyuki Shigematsu; Atsushi Kubo; Tomonaru Yajima; Toshifumi Hibi; Yasuo Ikeda; Shinichiro Okamoto
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

10.  Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation.

Authors:  Sandra K Call; Kimberly A Kasow; Raymond Barfield; Renee Madden; Wing Leung; Edwin Horwitz; Paul Woodard; John C Panetta; Sharyn Baker; Rupert Handgretinger; John Rodman; Gregory A Hale
Journal:  Biol Blood Marrow Transplant       Date:  2009-02       Impact factor: 5.742
View more
  1 in total

Review 1.  Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.

Authors:  Jeannine S McCune; Meagan J Bemer; Janel Long-Boyle
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.